KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Medpace Holdings (MEDP) over the last 6 years, with Q3 2025 value amounting to $29.7 million.

  • Medpace Holdings' Shares Outstanding (Diluted Average) fell 741.09% to $29.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.7 million, marking a year-over-year decrease of 741.09%. This contributed to the annual value of $32.0 million for FY2024, which is 54.33% up from last year.
  • Per Medpace Holdings' latest filing, its Shares Outstanding (Diluted Average) stood at $29.7 million for Q3 2025, which was down 741.09% from $30.2 million recorded in Q2 2025.
  • Medpace Holdings' 5-year Shares Outstanding (Diluted Average) high stood at $37.7 million for Q4 2021, and its period low was $29.7 million during Q3 2025.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $32.1 million (2024), whereas its average is $33.0 million.
  • As far as peak fluctuations go, Medpace Holdings' Shares Outstanding (Diluted Average) tumbled by 1157.46% in 2023, and later skyrocketed by 78.21% in 2024.
  • Over the past 5 years, Medpace Holdings' Shares Outstanding (Diluted Average) (Quarter) stood at $37.7 million in 2021, then decreased by 10.68% to $33.7 million in 2022, then fell by 5.43% to $31.8 million in 2023, then rose by 0.54% to $32.0 million in 2024, then decreased by 7.2% to $29.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $29.7 million in Q3 2025, compared to $30.2 million in Q2 2025 and $31.2 million in Q1 2025.